Ledger.Open graph →
SEC Form D · filed April 1, 2020

Galavant Therapeutics, Inc

Offering
$100K
Sold
$100K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Jonathan Waldstreicher · Menlo Park, CAExec · DirectorSeth Harrison · Cambridge, MADirectorJonathan Waldstreicher · Menlo Park, CAExec · DirectorSeth Harrison · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗